• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Expert Analysis: Solana vs. Cardano

chest

Market expert Anders Bylund compares Solana and Cardano, highlighting Solana's speed and low transaction costs against Cardano's research-first approach.

user avatarEmily Carter

Charles Schwab Plans 2027 Rollout of Crypto Trading for Advisors

chest

Charles Schwab is set to enhance its custody platform by introducing spot trading, transfer, and custody capabilities for financial advisors by 2027.

user avatarTomas Novak

Market Shows Signs of Weakness Despite Positive Sentiment

chest

Market shows signs of weakness despite positive sentiment in the crypto derivatives market.

user avatarKaterina Papadopoulou

Crypto expert forecasts optimistic outlook for Dogecoin.

chest

A crypto analyst, Crypto Patel, predicts a bullish future for Dogecoin, suggesting a potential rally towards $2 based on historical market patterns.

user avatarMaya Lundqvist

Other Crypto-Related Stocks Suffer Losses

chest

Other crypto-related stocks experienced significant losses in recent trading sessions, with BitMine and Sharplink falling 46.2% and 61.4%, respectively.

user avatarLeo van der Veen

Binance Being Examined for Possible Breaches of Sanctions.

chest

Senator Richard Blumenthal has raised concerns about Binance's potential involvement in facilitating violations of US and international sanctions related to Iran.

user avatarLi Weicheng

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.